FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.89B
1-Year Est. Return 201.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+201.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.34B
AUM Growth
+$837M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1 +$23.2M
2 +$14.5M
3 +$13.8M
4
DYN icon
Dyne Therapeutics
DYN
+$13.8M
5
ZLAB icon
Zai Lab
ZLAB
+$11M

Top Sells

1 +$21.1M
2 +$20M
3 +$12.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.5M
5
TVTX icon
Travere Therapeutics
TVTX
+$11.5M

Sector Composition

1 Healthcare 99.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$498M 14.93%
6,795,121
2
$475M 14.23%
16,701,956
+94,882
3
$361M 10.82%
3,383,950
4
$200M 5.98%
3,845,457
+45,000
5
$186M 5.58%
9,874,511
6
$147M 4.4%
12,466,489
7
$122M 3.64%
688,460
8
$118M 3.55%
4,567,274
-1
9
$116M 3.49%
6,652,013
+666,666
10
$95.1M 2.85%
1,438,534
-216,300
11
$93.9M 2.81%
10,259,409
12
$69.4M 2.08%
1,167,527
-230,000
13
$61.4M 1.84%
5,039,867
+152,000
14
$55.1M 1.65%
1,627,320
+319,182
15
$51.4M 1.54%
1,279,754
16
$49.6M 1.48%
22,729,436
17
$48.9M 1.47%
890,445
+335,714
18
$46.6M 1.4%
997,455
19
$45.3M 1.36%
722,400
20
$40.9M 1.23%
11,462,301
21
$34.4M 1.03%
2,718,105
+1,212,121
22
$32.1M 0.96%
+378,300
23
$31.5M 0.94%
5,100,000
24
$29.6M 0.89%
983,715
25
$29.4M 0.88%
4,424,725